EichorEICHOR
Condition: Stage A Pancreatic Cancer Synced from ClinicalTrials.gov · August 10, 2026

Recruiting studies: Stage A Pancreatic Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of GC203 TIL in PDCA (RJ)
EARLY_Phase 1 · 1 location(s) · Shanghai Juncell Therapeutics · NCT06828328A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Phase 1 · 8 location(s) · Erasca, Inc. · NCT06983743Study of JYP0015 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Phase 2 · 1 location(s) · Guangzhou JOYO Pharma Co., Ltd · NCT06895031Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
Phase 1/Phase 2 · 9 location(s) · Sichuan Enray Pharmaceutical Sciences Company · NCT07433283IN10018+ Standard Chemotherapy (+KN046) in Subjects With Advanced Pancreatic Cancer
Phase 1/Phase 2 · 1 location(s) · InxMed (Shanghai) Co., Ltd. · NCT0582779624BRO681 : Alternating Gnp and mFOLFIRINOX for BR-PDAC
Phase 2 · 1 location(s) · Dartmouth-Hitchcock Medical Center · NCT07043270AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
Phase 1 · 3 location(s) · Avacta Life Sciences Ltd · NCT07454642Axelopran for Advanced Cancer in Patients Receiving Opioids
Phase 2 · 2 location(s) · HealthPartners Institute · NCT07354919A Study of More Frequent Dosing of VCN-01 Combined With Standard Chemotherapy in Patients With Newly Diagnosed Metastati
Phase 1/Phase 2 · 1 location(s) · Theriva Biologics SL · NCT07701486A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerabili
Phase 1/Phase 2 · 10 location(s) · Lumara Bio Oncologics GmbH · NCT05706129A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Phase 1 · 62 location(s) · Seagen, a wholly owned subsidiary of Pfizer · NCT05208762A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
Phase 2 · 23 location(s) · Verastem, Inc. · NCT07644559A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Phase 1 · 30 location(s) · Pfizer · NCT07090499Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
Phase 1 · 18 location(s) · AstraZeneca · NCT06218914A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Phase 1 · 21 location(s) · Clasp Therapeutics, Inc. · NCT06778863Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally A
Phase 1/Phase 2 · 44 location(s) · National Cancer Institute (NCI) · NCT04172532Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Phase 1/Phase 2 · 7 location(s) · MBrace Therapeutics · NCT07145255Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis
Phase 2 · 1 location(s) · Mayo Clinic · NCT04858009Pembrolizumab With Olaparib as Combined Therapy in Metastatic Pancreatic Cancer
Phase 2 · 17 location(s) · Cambridge University Hospitals NHS Foundation Trust · NCT05093231A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas
Phase 1 · 3 location(s) · Boehringer Ingelheim · NCT06882746A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced
Phase 1/Phase 2 · 16 location(s) · BioNTech SE · NCT07186842Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors
Phase 1 · 10 location(s) · National Cancer Institute (NCI) · NCT05687123Adapted Guided Stereotactic Body Radiotherapy Combined With Chemotherapy and Enhancement of Novel Drug Ivonescimab for P
Phase 1/Phase 2 · 1 location(s) · Shandong Cancer Hospital and Institute · NCT06844422A Phase 2 Study of ABSK021 in Patients With Advanced Pancreatic Cancer
Phase 2 · 5 location(s) · Abbisko Therapeutics Co, Ltd · NCT06111274The Purpose of This Study is to Evaluate the Safety, Tolerability and Efficacy of TMT101 Injection Monotherapy in Patien
Phase 1 · 1 location(s) · Peking Union Medical College Hospital · NCT06861543A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-8989 in Patien
Phase 1/Phase 2 · 1 location(s) · Shenzhen Ionova Life Sciences Co., Ltd. · NCT07610798Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors
Phase 1/Phase 2 · 25 location(s) · AstraZeneca · NCT06005493A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Phase 1/Phase 2 · 82 location(s) · Artios Pharma Ltd · NCT04657068A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic So
Phase 1/Phase 2 · 120 location(s) · Daiichi Sankyo · NCT06330064Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
NA · 13 location(s) · European Organisation for Research and Treatment of Cancer - · NCT04498767
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.